Goran Mićević, MD, PhD,

Dr. Micevic completed his MD and PhD degrees at Yale School of Medicine. His doctorate focused on epigenetic changes in melanoma formation and progression with Dr. Marcus Bosenberg. He completed dermatology residency at Yale New Haven Hospital and dermatopathology fellowship. For his post-doctoral work, he joined the lab of Dr. Richard Flavell at the Yale Department of Immunobiology, where he investigated the immune cell populations required for long-term response/anti-tumor memory in the setting of checkpoint inihibitor therapy in melanoma.